MedTrace Logo

Implants Placement with Simultaneous Soft Tissue Augmentation Using a Collagen Matrix Compared to Connective Tissue Graft: a Pilot Study

NCT06585813 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2024-09-19

No results posted yet for this study

Summary

Background: To our knowledge, no study evaluated the use of VCMX at multiple implant sites and compared its efficacy and safety to a SCTG with the same dimensions. Therefore, we propose in the present protocol to evaluate the efficacy of VMCX to increase the thickness and height of soft tissue when placed at the time of multiple implant placement, as compared to SCTG.

Material and Methods: This study will be conducted in the saint joseph university periodontology department on at least 5 to 10 patients. The studied sites are the edentulous posterior mandible in a split-mouth model. The test groups are the groups grafted with VCMX and the control groups are the groups grafted with SCTG.

Some studies have been reported to compare these two techniques. But the specificity of our study is soft tissue augmentation on multiple implant sites in a split-mouth design.

Conditions

  • Soft Tissue Thickness Arround Implants

Interventions

PROCEDURE

dental implant

we placed our implants and simultaneously grafted either fibroguide or CTG and after 3 months we did the second stage surgery

PROCEDURE

Fibrogide membrane

we were comparing the efficacy of Fibrogide with the Connective tissue graft

PROCEDURE

connective tissue graft

the control group was the connective tissue graft group and the test group was the Fibrogide group

PROCEDURE

second stage

second stage to determine the thickness gained after the graft and to place a healing abutment

Sponsors & Collaborators

  • Saint-Joseph University

    lead OTHER

Principal Investigators

  • Nada Naaman, DDS,Msc in periodontology,PHD · Saint-Joseph University /American University of Baghdad

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-10
Primary Completion
2024-04-29
Completion
2024-06-20

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06585813 on ClinicalTrials.gov